Israel Cancer Association
8
1
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
25.0%
2 terminated/withdrawn out of 8 trials
50.0%
-36.5% vs industry average
25%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers
Role: collaborator
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Role: collaborator
Combined Model of Online Remote Interventions for Cancer-Related Cognitive Impairment
Role: collaborator
Quality of Life in Children Cured of Retinoblastoma
Role: collaborator
Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation
Role: collaborator
Physical Activity and Health of Children With Cancer in Remission
Role: collaborator
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
Role: collaborator
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
Role: collaborator
All 8 trials loaded